<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Toxicol</journal-id><journal-id journal-id-type="iso-abbrev">Arch. Toxicol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Archives of Toxicology</journal-title></journal-title-group><issn pub-type="ppub">0340-5761</issn><issn pub-type="epub">1432-0738</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5225275</article-id><article-id pub-id-type="pmcid-ver">PMC5225275.1</article-id><article-id pub-id-type="pmcaid">5225275</article-id><article-id pub-id-type="pmcaiid">5225275</article-id><article-id pub-id-type="pmid">27136898</article-id><article-id pub-id-type="doi">10.1007/s00204-016-1720-0</article-id><article-id pub-id-type="publisher-id">1720</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Molecular Toxicology</subject></subj-group></article-categories><title-group><article-title>2,3,7,8 Tetrachlorodibenzo-<italic toggle="yes">p</italic>-dioxin-induced RNA abundance changes identify <italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Col18a1</italic>, <italic toggle="yes">Cyb5a</italic> and <italic toggle="yes">Glud1</italic> as candidate mediators of toxicity</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Watson</surname><given-names initials="JD">John D.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prokopec</surname><given-names initials="SD">Stephenie D.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="AB">Ashley B.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Okey</surname><given-names initials="AB">Allan B.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names initials="R">Raimo</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Boutros</surname><given-names initials="PC">Paul C.</given-names></name><address><phone>416-673-8564</phone><email>Paul.Boutros@oicr.on.ca</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label>Informatics and Bio-computing Program, MaRS Centre, Ontario Institute for Cancer Research, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3 Canada </aff><aff id="Aff2"><label>2</label>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada </aff><aff id="Aff3"><label>3</label>Laboratory of Toxicology, National Institute for Health and Welfare, Kuopio, Finland </aff><aff id="Aff4"><label>4</label>Department of Food Hygiene and Environmental Health, University of Helsinki, Helsinki, Finland </aff><aff id="Aff5"><label>5</label>Department of Medical Biophysics, University of Toronto, Toronto, Canada </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>91</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">283792</issue-id><fpage>325</fpage><lpage>338</lpage><history><date date-type="received"><day>3</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>4</month><year>2016</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>04</month><year>2016</year></date></event><event event-type="pmc-live"><date><day>24</day><month>01</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-14 17:25:13.707"><day>14</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="204_2016_Article_1720.pdf"/><abstract id="Abs1"><p>2,3,7,8 Tetrachlorodibenzo-<italic toggle="yes">p</italic>-dioxin (TCDD) is an aromatic, long-lived environmental contaminant. While the pathogenesis of TCDD-induced toxicity is poorly understood, it has been shown that the aryl hydrocarbon receptor (AHR) is required. However, the specific transcriptomic changes that lead to toxic outcomes have not yet been identified. We previously identified a panel of 33 genes that respond to TCDD treatment in two TCDD-sensitive rodent species. To identify genes involved in the onset of hepatic toxicity, we explored 25 of these in-depth using liver from two rat strains: the TCDD-resistant Han/Wistar (H/W) and the TCDD-sensitive Long&#8211;Evans (L&#8211;E). Time course and dose&#8211;response analyses of mRNA abundance following TCDD insult indicate that eight genes are similarly regulated in livers of both strains of rat, suggesting that they are not central to the severe L&#8211;E-specific TCDD-induced toxicities. The remaining 17 genes exhibited various divergent mRNA abundances between L&#8211;E and H/W strains after TCDD treatment. Several genes displayed a biphasic response where the initial response to TCDD treatment was followed by a secondary response, usually of larger magnitude in L&#8211;E liver. This secondary response was most often an exaggeration of the original TCDD-induced response. Only cytochrome b5 type A (microsomal) (<italic toggle="yes">Cyb5a</italic>) had equivalent TCDD sensitivity to the prototypic AHR-responsive cytochrome P450, family 1, subfamily a, polypeptide 1 (<italic toggle="yes">Cyp1a1</italic>), while six genes were less sensitive. Four genes showed an early inter-strain difference that was sustained throughout most of the time course (atypical chemokine receptor 3 (<italic toggle="yes">Ackr3</italic>), collagen, type XVIII, alpha 1 (<italic toggle="yes">Col18a1</italic>), <italic toggle="yes">Cyb5a</italic> and glutamate dehydrogenase 1 (<italic toggle="yes">Glud1</italic>)), and of those genes examined in this study, are most likely to represent genes involved in the pathogenesis of TCDD-induced hepatotoxicity in L&#8211;E rats.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00204-016-1720-0) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Aryl hydrocarbon receptor</kwd><kwd>2,3,7,8 Tetrachlorodibenzo-p-dioxin</kwd><kwd>TCDD</kwd><kwd>mRNA abundance</kwd><kwd>NanoString</kwd><kwd>Toxicity</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>MOP-57903</award-id><principal-award-recipient><name name-style="western"><surname>Okey</surname><given-names>Allan B.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Suomen Akatemia</institution></institution-wrap></funding-source><award-id>123345</award-id><award-id>261232</award-id><principal-award-recipient><name name-style="western"><surname>Pohjanvirta</surname><given-names>Raimo</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004203</institution-id><institution>Ontario Institute for Cancer Research</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag Berlin Heidelberg 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>The environmental contaminant 2,3,7,8 tetrachlorodibenzo-<italic toggle="yes">p</italic>-dioxin (TCDD) is a highly stable aromatic compound that causes a wide variety of toxic phenotypes. Specific toxic effects vary across species, but in mammals can include hepatic toxicity, chloracne, teratogenic effects, thymic atrophy, immune dysregulation, rapid weight loss (known as wasting syndrome) and cancer (Birnbaum and Tuomisto <xref ref-type="bibr" rid="CR3">2000</xref>; Pohjanvirta and Tuomisto <xref ref-type="bibr" rid="CR57">1994</xref>; White and Birnbaum <xref ref-type="bibr" rid="CR100">2009</xref>). TCDD is highly lipophilic and poorly metabolized, and thus bio-accumulates within fat stores of animals higher up the food chain and represents a long-term, cumulative source of toxicity (Domingo and Bocio <xref ref-type="bibr" rid="CR13">2007</xref>; Sinkkonen and Paasivirta <xref ref-type="bibr" rid="CR71">2000</xref>; van Birgelen and van den Berg <xref ref-type="bibr" rid="CR89">2000</xref>).</p><p>While TCDD exposure leads to toxicity in most vertebrate species, there is a high degree of variation in susceptibility, both between species and within species. Notably, the Han/Wistar (<italic toggle="yes">Kuopio</italic>) rat (H/W) is exceptionally resistant to TCDD-induced toxicities (LD<sub>50</sub> above 9600&#160;&#956;g/kg), while guinea pigs are at least 10,000-fold more sensitive, with an LD<sub>50</sub> of 1&#8211;2&#160;&#956;g/kg (Pohjanvirta and Tuomisto <xref ref-type="bibr" rid="CR57">1994</xref>; Pohjanvirta et al. <xref ref-type="bibr" rid="CR61">1999</xref>). Most mammalian species fall between these extremes: commonly used experimental models such as the Long&#8211;Evans (<italic toggle="yes">Turku/</italic>AB; L&#8211;E) rat and C57BL/6 mouse have intermediate sensitivity (LD<sub>50</sub> of 17.7 and ~182&#160;&#956;g/kg for male animals, respectively) (Pohjanvirta and Tuomisto <xref ref-type="bibr" rid="CR57">1994</xref>). In addition to variation in sensitivity among species, the specific tissues and organ systems affected by TCDD ingestion vary widely among species. In humans, the most obvious outcome of exposure to high doses of TCDD is chloracne, whereas wasting syndrome and delayed death are most notable in rodents (Sorg et al. <xref ref-type="bibr" rid="CR72">2009</xref>; Sweeney and Mocarelli <xref ref-type="bibr" rid="CR77">2000</xref>; Tuomisto et al. <xref ref-type="bibr" rid="CR82">1995</xref>). Studies of human populations exposed to TCDD and related congeners (resulting from industrial accidents and food contamination) have implicated TCDD as a human carcinogen, although this finding is widely debated due to confounding factors (Consonni et al. <xref ref-type="bibr" rid="CR11">2008</xref>; Pesatori et al. <xref ref-type="bibr" rid="CR55">2009</xref>; Tuomisto and Tuomisto <xref ref-type="bibr" rid="CR81">2012</xref>; US-EPA <xref ref-type="bibr" rid="CR88">2003</xref>).</p><p>Despite wide variation in sensitivity and differing manifestations of toxicity among species, the toxic effects of TCDD have been mainly attributed to activation of the aryl hydrocarbon receptor (AHR) (Okey <xref ref-type="bibr" rid="CR53">2007</xref>). The AHR is a ligand-activated transcription factor of the Per-Arnt-Sim family and alters transcription of numerous genes (Kewley et al. <xref ref-type="bibr" rid="CR34">2004</xref>). Upon ligand binding, the AHR is translocated into the cell nucleus where it heterodimerizes with the aryl hydrocarbon nuclear translocator (ARNT), subsequently binding to AHR response elements (AHREs) in upstream regulatory regions of target genes such as <italic toggle="yes">Cyp1a1</italic> (Lindebro et al. <xref ref-type="bibr" rid="CR39">1995</xref>). Studies in mice have shown that mutations which reduce the affinity of AHR for TCDD correlate with a reduction in toxic outcome (Birnbaum et al. <xref ref-type="bibr" rid="CR4">1990</xref>; Okey et al. <xref ref-type="bibr" rid="CR54">1989</xref>). In the H/W rat, a point mutation that alters the AHR transactivation domain via alternative splicing imparts great resistance to TCDD-induced toxicities (Pohjanvirta et al. <xref ref-type="bibr" rid="CR60">1998</xref>; Simanainen et al. <xref ref-type="bibr" rid="CR69">2002</xref>). It is interesting that the resistance of H/W rats to the toxic effects of TCDD exposure occurs despite the variant H/W AHR maintaining the ability to regulate transcriptional changes in numerous &#8220;AHR-core&#8221; genes (such as <italic toggle="yes">Cyp1a1</italic>) in a manner similar to TCDD-sensitive L&#8211;E rats (Moffat et al. <xref ref-type="bibr" rid="CR48">2010</xref>; Simanainen et al. <xref ref-type="bibr" rid="CR69">2002</xref>). Responses that are conserved between sensitive and resistant rat strains are termed type I, while responses that are enhanced in or exclusive to TCDD-sensitive L&#8211;E rats are termed type II responses (Simanainen et al. <xref ref-type="bibr" rid="CR69">2002</xref>, <xref ref-type="bibr" rid="CR70">2003</xref>).</p><p>It has also been shown that heterodimerization of the AHR with ARNT is required for TCDD-induced toxicity in mouse liver (Nukaya et al. <xref ref-type="bibr" rid="CR52">2010</xref>), and that mice hypomorphic for ARNT are resistant to TCDD-induced effects (Walisser et al. <xref ref-type="bibr" rid="CR95">2004a</xref>, <xref ref-type="bibr" rid="CR96">b</xref>). However, the clearest evidence that TCDD toxicity is AHR dependent comes from studies of AHR knockout mice. Mice lacking an AHR do not suffer the toxic effects of TCDD (Bunger et al. <xref ref-type="bibr" rid="CR8">2003</xref>; Fernandez-Salguero et al. <xref ref-type="bibr" rid="CR17">1996</xref>; Mimura et al. <xref ref-type="bibr" rid="CR47">1997</xref>; Vorderstrasse et al. <xref ref-type="bibr" rid="CR93">2001</xref>). While some studies have identified non-genomic pathways leading to metabolic alterations (Li et al. <xref ref-type="bibr" rid="CR37">2010</xref>; Matsumura <xref ref-type="bibr" rid="CR45">2009</xref>), the studies discussed above indicate that DNA binding of the AHR:ARNT heterodimer is required to mediate the major toxic outcomes of dioxin exposure.</p><p>Identification of the key transcriptional changes that lead to toxicity in laboratory species has been difficult. Activation of the AHR alters the abundance of hundreds to thousands of different mRNAs (Boutros et al. <xref ref-type="bibr" rid="CR5">2008</xref>; Boverhof et al. <xref ref-type="bibr" rid="CR7">2006</xref>; Forgacs et al. <xref ref-type="bibr" rid="CR20">2013</xref>; Sato et al. <xref ref-type="bibr" rid="CR66">2008</xref>; Tijet et al. <xref ref-type="bibr" rid="CR79">2006</xref>). While a core set of genes is affected across a wide biological spectrum (termed &#8220;AHR-core&#8221; genes), the majority of transcriptomic responses appear to depend upon the species, strain, tissue and cell type (Boutros et al. <xref ref-type="bibr" rid="CR5">2008</xref>; Boverhof et al. <xref ref-type="bibr" rid="CR7">2006</xref>; Carlson et al. <xref ref-type="bibr" rid="CR10">2009</xref>; Puga et al. <xref ref-type="bibr" rid="CR63">2004</xref>; Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>). In general, &#8220;AHR-core&#8221; genes are involved in pathways for detoxification (<italic toggle="yes">e.g.</italic>
<italic toggle="yes">Cyp1a1</italic>), oxidative stress [e.g. nuclear factor, erythroid 2-like 2 (<italic toggle="yes">Nfe2l2</italic>)] and negative feedback regulation [e.g. aryl hydrocarbon receptor repressor (<italic toggle="yes">Ahrr</italic>)]. This complex variation in transcriptional response is coupled to a large degree of intra-species and even intra-strain variation in the pattern of phenotypic responses to TCDD treatment described above. Indeed, the large intra-species variability in TCDD-induced changes is a reflection of large differences in the basal transcriptome across strains of rats (Yao et al. <xref ref-type="bibr" rid="CR101">2012</xref>) and mice (Pritchard et al. <xref ref-type="bibr" rid="CR62">2006</xref>).</p><p>Fortunately, these variations also provide a tool that can be used to identify genes involved in toxicity. Recent studies by our group (Boutros et al. <xref ref-type="bibr" rid="CR5">2008</xref>) and others (Boverhof et al. <xref ref-type="bibr" rid="CR7">2006</xref>) have compared mouse and rat, two TCDD-sensitive laboratory animals that have similar phenotypic responses to TCDD. Comparison of hepatic mRNA abundance changes following TCDD treatment identified several genes which were dysregulated in both species and may be involved in the onset of liver toxicity. While each of these studies identified 33 genes that were similarly regulated in both mouse and rat, only three genes [<italic toggle="yes">Cyp1a1</italic>, NAD(P)H dehydrogenase, quinone 1 (<italic toggle="yes">Nqo1</italic>) and glutamate dehydrogenase 1 (<italic toggle="yes">Glud1</italic>)] were identified in both studies. Continuing from the detailed analysis of eight &#8220;AHR-core&#8221; genes (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>), the remaining 25 TCDD-responsive genes identified in our rat&#8211;mouse comparison are analysed in detail here. We compare changes in hepatic mRNA abundance between the TCDD-resistant H/W rat and the TCDD-sensitive L&#8211;E rat. By identifying genes whose expression differs between dioxin-sensitive and dioxin-resistant rats following TCDD exposure, we have identified candidate regulators of type II phenotypic responses.</p></sec><sec id="Sec2"><title>Methods and materials</title><sec id="Sec3"><title>Animal handling</title><p>Samples used in this study were the same as previously described (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>). This manuscript does not contain any clinical studies or patient data. Study plans were approved by the Kuopio Provincial Government and the Animal Experiment Committee of the University of Kuopio. Briefly, four experimental (TCDD treated) rats were used for each dose studied (0.001, 0.01, 0.1, 1, 10, 50, 100, 1000 or 3000&#160;&#956;g/kg, Fig. S1), and livers were harvested 19-h post-gavage with TCDD in corn oil. The time course study animals were treated with a single 100&#160;&#956;g/kg dose of TCDD in corn oil, and the liver was harvested at the appropriate times following treatment; L&#8211;E animals were harvested at 3-, 6-, 10-, 19-, 96- and 240-h post-TCDD treatment (<italic toggle="yes">n</italic>&#160;=&#160;4, 4, 4, 4, 4, 5, respectively), and H/W animals were harvested at 1.5, 3, 6, 10, 19, 96, 240 and 384&#160;h after TCDD treatment (<italic toggle="yes">n</italic>&#160;=&#160;3, 4, 4, 4, 4, 5, 5, 4, respectively). In addition, animals treated by gavage with corn oil vehicle were harvested at several time points as controls [L&#8211;E: 19, 96 and 240&#160;h (<italic toggle="yes">n</italic>&#160;=&#160;7, 4, 5, respectively), H/W: 1.5, 19, 96, 240 and 384&#160;h (<italic toggle="yes">n</italic>&#160;=&#160;3, 7, 5, 5, 4, respectively), Fig. S1]. Animal weights are reported in File S1. ARRIVE guidelines for reporting animal experimentation were followed (Kilkenny et al. <xref ref-type="bibr" rid="CR35">2010</xref>) as outlined in the ARRIVE checklist (File S2).</p></sec><sec id="Sec4"><title>RNA isolation</title><p>RNA was extracted from rat liver using RNeasy Mini kits (Qiagen, Mississauga, Canada) following the manufacturer&#8217;s recommended protocol. RNA was quantified using a NanoDrop spectrophotometer, and the integrity of the RNA was verified by electrophoresis on an Agilent 2100 Bioanalyzer, using RNA Nano 6000 total RNA assays. Only RNA samples with an RNA integrity number (RIN) greater than 8.5 were used in downstream analyses. RIN numbers are available in Watson et al. (<xref ref-type="bibr" rid="CR98">2013</xref>), as Supplementary File 1.</p></sec><sec id="Sec5"><title>RNA analysis</title><p>RNA was diluted to a concentration of 50&#160;ng/&#181;l, and 50&#160;&#181;l of each sample was loaded into one well of a 96-well plate and sent to the UHN Microarray Centre (Toronto, ON) on dry ice for analysis on a NanoString nCounter. Desired mRNA targets were submitted in advance, and probes were designed and synthesized by NanoString prior to RNA analysis. Probes were verified by BLAST analysis (Johnson et al. <xref ref-type="bibr" rid="CR32">2008</xref>), searching the <italic toggle="yes">Rattus norvegicus</italic> nr/nt database to ensure that each identified a single gene. The CodeSet (the multiplexed collection of 54 distinct probes) used is provided in File S2. All raw and pre-processed data and the CodeSet have been deposited in the NCBI&#8217;s Gene Expression Omnibus (Edgar et al. <xref ref-type="bibr" rid="CR15">2002</xref>) as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE43251">GSE43251</ext-link>. Each sample was analysed in a separate hybridization reaction containing the entire CodeSet, and the NanoString data were pre-processed as previously described (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>). The NanoStringNorm (version 0.9.4) package, designed for use in the R statistical environment, provides all pre-processing methods for NanoString data (Waggott et al. <xref ref-type="bibr" rid="CR94">2011</xref>). Since time-matched vehicle controls were not available for all time points, the 19-h vehicle control was used as the basal level for subsequent analyses. Statistical analysis indicated that use of the 19-h control instead of the available time-matched controls did not significantly alter the results (Supplementary Fig.&#160;3 of Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>).</p></sec><sec id="Sec6"><title>Statistical analysis</title><p>Data were analysed in the R statistical environment (version 3.2.1) using unpaired Student&#8217;s <italic toggle="yes">t</italic> tests to compare strains, doses and time points (Ihaka and Gentleman <xref ref-type="bibr" rid="CR30">1996</xref>). <italic toggle="yes">p</italic> values were false discovery rate corrected (<italic toggle="yes">p</italic>
<sub>adjusted</sub>) to adjust for multiple testing (Storey and Tibshirani <xref ref-type="bibr" rid="CR74">2003</xref>). ED<sub>50</sub> values with 90&#160;% confidence intervals were determined by fitting response curves using a four-parameter log-logistic model (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f(x) = c + [\{ d - c\} /1 + \exp (b(\log (x) - \tilde{e}))]$$\end{document}</tex-math><mml:math id="M2" overflow="scroll"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mi>d</mml:mi><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">}</mml:mo></mml:mrow><mml:mo stretchy="false">/</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>b</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>log</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mover accent="true"><mml:mi>e</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_Article_IEq1.gif"/></alternatives></inline-formula>), where <italic toggle="yes">b</italic>&#160;=&#160;slope at the inflection point, <italic toggle="yes">c</italic>&#160;=&#160;lower limit, <italic toggle="yes">d</italic>&#160;=&#160;upper limit and <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\tilde{e} = \log (ED_{50} )$$\end{document}</tex-math><mml:math id="M4" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mi>e</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>log</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mn>50</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_Article_IEq2.gif"/></alternatives></inline-formula>) using the R package drc (version 2.5-12). ED<sub>50</sub> with 90&#160;% confidence intervals was determined by drc as part of the curve fitting. Differences in ED<sub>50</sub> parameter values were determined between strains and <italic toggle="yes">p</italic> values generated by means of approximate <italic toggle="yes">t</italic> tests (Ritz and Streibig <xref ref-type="bibr" rid="CR65">2005</xref>). Data were visualized using the lattice (version 0.20-33) and latticeExtra (version 0.6-26) packages via the BPG package (P&#8217;ng et al. submitted; version 5.3.4). All error bars represent standard error of the mean. ED<sub>50</sub> values were compared using inferential confidence intervals with &#916;&#160;=&#160;2&#160;&#215;&#160;ED<sub>50</sub> 90&#160;% confidence range for <italic toggle="yes">Cyp1a1</italic> to determine whether any gene(s) had an ED<sub>50</sub> value statistically equivalent to <italic toggle="yes">Cyp1a1</italic> (Beckstead <xref ref-type="bibr" rid="CR2">2008</xref>; Tryon and Lewis <xref ref-type="bibr" rid="CR80">2008</xref>).</p></sec></sec><sec id="Sec7"><title>Results</title><p>We previously identified 33 genes that may be involved in the onset of TCDD toxicity, having changes in liver mRNA abundance that occur in common between two rodent species that display similar phenotypic responses to TCDD (Boutros et al. <xref ref-type="bibr" rid="CR5">2008</xref>). The goal of our current study was to validate and prioritize candidate genes for subsequent mechanistic analysis. We chose to examine the less-studied TCDD-responsive genes by excluding the well-documented &#8220;AHR-core&#8221; genes. Here, we compare changes in hepatic mRNA abundances following TCDD treatment of TCDD-sensitive L&#8211;E rats with TCDD-resistant H/W rats. These rat strains differ widely in their phenotypic response to TCDD (Pohjanvirta et al. <xref ref-type="bibr" rid="CR61">1999</xref>). We therefore hypothesize that genes displaying conserved responses in TCDD-sensitive L&#8211;E rats and C57BL/6 mice but that demonstrate differential expression patterns between L&#8211;E and TCDD-resistant H/W rats play a role in the onset of toxicity.</p><sec id="Sec8"><title>Time course analysis</title><p>The NanoString platform was used to analyse effects of TCDD treatment on the mRNA abundance of a subset of TCDD-regulated genes in livers of H/W and L/E rats. The utility of the approach has been validated previously by analysis of a well-characterized TCDD-regulated gene, <italic toggle="yes">Cyp1a1</italic> (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>). A summary of the mRNA abundance changes for all genes examined is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. Eight genes showed similar mRNA responses following TCDD treatment in both strains (growth factor, augmenter of liver regeneration (<italic toggle="yes">Gfer</italic>), influenza virus NS1A-binding protein (<italic toggle="yes">Ivns1abp</italic>), phenazine biosynthesis-like protein domain containing 1 (<italic toggle="yes">Pbld</italic>), phosphodiesterase 2A (<italic toggle="yes">Pde2a</italic>), proteasome maturation protein (<italic toggle="yes">Pomp</italic>), solute carrier organic anion transporter family, member 1a1 (<italic toggle="yes">Slco1a1</italic>), tropomyosin 1, alpha (<italic toggle="yes">Tpm1</italic>) and UV radiation resistance-associated gene (<italic toggle="yes">Uvrag</italic>); Figs. S2&#8211;S9). Differences in the mRNA response profiles for L&#8211;E and H/W rats were defined as those with significantly different inter-strain mRNA abundances (in the same direction) at two or more consecutive time points (<italic toggle="yes">p</italic>
<sub>adjusted</sub>&#160;&lt;&#160;0.10). This criterion was met for 17/25 genes (<italic toggle="yes">Ackr3</italic>, cysteine conjugate-beta lyase, cytoplasmic (<italic toggle="yes">Ccbl1</italic>), <italic toggle="yes">Col18a1</italic>, <italic toggle="yes">Cyb5a</italic>, derlin 1 (<italic toggle="yes">Derl1</italic>), echinoderm microtubule-associated protein like 4 (<italic toggle="yes">Eml4</italic>), endoplasmic reticulum to nucleus signalling 1 (<italic toggle="yes">Ern1</italic>), exocyst complex component 3 (<italic toggle="yes">Exoc3</italic>), growth hormone receptor (<italic toggle="yes">Ghr</italic>), <italic toggle="yes">Glud1</italic>, LIM and SH3 protein 1 (<italic toggle="yes">Lasp1</italic>), neuraminidase 1 (<italic toggle="yes">Neu1</italic>), TP53 apoptosis effector (<italic toggle="yes">Perp</italic>), phosphomannomutase 1 (<italic toggle="yes">Pmm1</italic>), proteasome subunit beta 4 (<italic toggle="yes">Psmb4</italic>), syndecan 1 (<italic toggle="yes">Sdc1</italic>) and sulfiredoxin 1 (<italic toggle="yes">Srxn1</italic>); Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, Figs. S10&#8211;S22). Furthermore, we deemed it most likely that a gene responsible for prolonged toxicity would exhibit significant inter-strain differences at three or more consecutive time points. Using these criteria, four genes were identified as being potentially involved in L&#8211;E-specific hepatic toxicity (<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Col18a1</italic> and <italic toggle="yes">Glud1</italic>, Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). While <italic toggle="yes">Ghr</italic> did not meet the above criteria for inter-strain differences, it demonstrated significantly different inter-strain mRNA abundance at four of the six time points (Fig. S15).<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Summary of transcriptional responses to TCDD exposure. Summary of mRNA abundance changes of all examined genes following TCDD treatment with animals evaluated along either a time course (a) or dose&#8211;response (b) experiment. <italic toggle="yes">Dot size</italic> Magnitude of change as a per cent of the maximal normalized expression level for that gene in either H/W or L&#8211;E rat (whichever strain has the highest expression level) to allow for direct comparison between strains. <italic toggle="yes">Shading of individual squares</italic> represents the FDR-adjusted <italic toggle="yes">p</italic> value for an unpaired Student&#8217;s <italic toggle="yes">t</italic> test comparing TCDD-induced expression to the 19-h vehicle control for each strain. Differences from vehicle controls were considered significant if two consecutive points in the time course (normalized expression levels, not fold change) were statistically significant at a <italic toggle="yes">p</italic>
<sub>adjusted</sub>&#160;&lt;&#160;0.10, resulting in an FDR-adjusted joint probability of &lt;0.01. H/W values are represented by blue circles, while L&#8211;E are represented by <italic toggle="yes">orange circles</italic> (colour figure online)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="204_2016_1720_Fig1_HTML.jpg"/></fig>
<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Summary of mRNA abundance changes following TCDD treatment. The dot size represents H/W per cent change&#8212;L&#8211;E per cent change values. Shading of individual squares represents the FDR-adjusted <italic toggle="yes">p</italic> value for an unpaired Student&#8217;s <italic toggle="yes">t</italic> test comparing the inter-strain differences. <italic toggle="yes">Orange circles</italic> indicate higher abundance in L&#8211;E, while blue circles indicate higher abundance in H/W. A <italic toggle="yes">red box</italic> to the right of the gene <italic toggle="yes">symbol</italic> indicates that this gene had a statistically significant difference between strains at two or more consecutive time points (colour figure online)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="204_2016_1720_Fig2_HTML.jpg"/></fig>
<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>
<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Col18a1 and Glud1</italic> are genes with prolonged differential responses. Hepatic mRNA abundances of <italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Col18a1</italic> and <italic toggle="yes">Glud1</italic> display significantly differences in response between strains at three or more consecutive time points following TCDD treatment. a Normalized mRNA abundance time course profiles of TCDD-treated animals; b animals were similarly evaluated along a dose&#8211;response study with samples collected at 19-h post-treatment. <italic toggle="yes">Asterisk</italic> indicates <italic toggle="yes">p</italic>
<sub>adjusted</sub>&#160;&lt;&#160;0.1 when comparing H/W to L&#8211;E using an unpaired Student&#8217;s <italic toggle="yes">t</italic> test</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="204_2016_1720_Fig3_HTML.jpg"/></fig>
</p><p>Genes could also be subdivided into groups defined by the time at which mRNA abundance began to deviate between H/W and L&#8211;E. Nine genes were observed to have differential inter-strain mRNA abundances beginning earlier than 10&#160;h post-treatment (<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Ccbl1</italic>, <italic toggle="yes">Col18a1</italic>, <italic toggle="yes">Exoc3</italic>, <italic toggle="yes">Ghr</italic>, <italic toggle="yes">Glud1</italic>, <italic toggle="yes">Lasp1</italic>, <italic toggle="yes">Psmb4</italic> and <italic toggle="yes">Sdc1</italic>; Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> and Figs. S10, S14&#8211;S16, S20, S21), while eight genes deviated at 10&#160;h or later after TCDD exposure (<italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Derl1</italic>, <italic toggle="yes">Eml4</italic>, <italic toggle="yes">Ern1</italic>, <italic toggle="yes">Neu1</italic>, <italic toggle="yes">Perp</italic>, <italic toggle="yes">Pmm1</italic> and <italic toggle="yes">Srxn1</italic>; Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref> and Figs. S11&#8211;S13, S17&#8211;S19, S22).</p></sec><sec id="Sec9"><title>&#8220;Biphasic&#8221; responses</title><p>Nine genes demonstrated &#8220;biphasic&#8221; mRNA abundance changes in response to the 100&#160;&#181;g/kg TCDD treatment. These genes reached an initial plateau or peak early after treatment (between 3- and 10-h post-treatment) followed by a secondary response, which in most cases represented an extension or exaggeration of the original change. The exception to this trend was <italic toggle="yes">Ern1</italic>, where an initial repression caused by TCDD treatment was reversed beginning at 19-h post-treatment in L&#8211;E rat liver. The abundance of <italic toggle="yes">Ern1</italic> rapidly returned to near control levels in L&#8211;E animals, but remained reduced in H/W liver (Fig. S13). In all other instances (<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Ccbl1</italic>, <italic toggle="yes">Exoc3</italic>, <italic toggle="yes">Neu1</italic>, <italic toggle="yes">Pde2a</italic>, <italic toggle="yes">Perp</italic>, <italic toggle="yes">Pmm1</italic> and <italic toggle="yes">Sxrn1</italic>; Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>; Figs. S5, S10, S14 S17&#8211;S19 and S22), L&#8211;E animals displayed a secondary exaggeration of the initial TCDD-induced change. H/W animals often exhibited the biphasic mRNA abundance pattern; however, with the exception of <italic toggle="yes">Ern1</italic>, the L&#8211;E secondary response occurred to a much larger magnitude than that observed in H/W liver.</p></sec><sec id="Sec10"><title>Dose&#8211;response analysis</title><p>Dose&#8211;response analyses were performed for all genes of interest at 19-h post-TCDD treatment. In most instances, the log dose&#8211;response curves presented the expected classic sigmoidal shape (Fig. S23). For some genes, both the dose&#8211;response and time course exhibited a muted response, indicating that the gene was poorly or non-responsive to TCDD at 19&#160;h (<italic toggle="yes">Uvrag</italic>; Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>; Figs. S9, S23). In general, the dose&#8211;response profiles showed less inter-strain variation than the time course analyses. For instance, <italic toggle="yes">Ccbl1</italic> displayed significant inter-strain differences in mRNA abundance at 3-, 6- and 240-h post-treatment; however, no difference was detected at the 19-h time point used for the dose&#8211;response study (Fig. S10). In contrast, <italic toggle="yes">Cyb5a</italic> is near its maximal time course response in H/W rats at 19&#160;h and this was reflected by the changes observed using the dose&#8211;response approach (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, Fig. S23). Only two genes had significant inter-strain differences in their ED<sub>50</sub> values (<italic toggle="yes">Cyb5a</italic> and <italic toggle="yes">Psmb4</italic>; Table&#160;<xref rid="Tab1" ref-type="table">1</xref>; Fig. S23). However, <italic toggle="yes">Ackr3</italic> could also be included here as it showed a very clear difference in the dose&#8211;response; L&#8211;E rats had an ED<sub>50</sub> of 8.3&#160;&#181;g/kg, whereas the ED<sub>50</sub> for H/W was not determinable since this gene was unresponsive in this strain until 240-h post-exposure (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Three additional genes had an ED<sub>50</sub> determined for only one strain (<italic toggle="yes">Lasp1</italic>, <italic toggle="yes">Srxn1</italic> and <italic toggle="yes">Tpm1</italic>). <italic toggle="yes">Lasp1</italic> and <italic toggle="yes">Srxn1</italic> were determined to have an ED<sub>50</sub> of 4.06 and 0.60 &#181;g/kg, respectively, in L&#8211;E animals while <italic toggle="yes">Tpm1</italic> had an ED<sub>50</sub> of 0.30 in H/W rats (Table&#160;<xref rid="Tab1" ref-type="table">1</xref> and Fig. S23).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Genes analysed for differential responses</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Gene symbol</th><th align="left" colspan="1" rowspan="1">TCDD response</th><th align="left" colspan="1" rowspan="1">Strain-related difference</th><th align="left" colspan="1" rowspan="1">ED<sub>50</sub> H/W&#160;&#181;g/kg</th><th align="left" colspan="1" rowspan="1">ED<sub>50</sub> L&#8211;E &#181;g/kg</th><th align="left" colspan="1" rowspan="1">Difference as per cent</th><th align="left" colspan="1" rowspan="1">Absolute difference</th><th align="left" colspan="1" rowspan="1">Gene ID</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Ackr3</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">8.30<sup>a</sup>
</td><td char="." align="char" colspan="1" rowspan="1">96.0</td><td char="." align="char" colspan="1" rowspan="1">3984</td><td char="." align="char" colspan="1" rowspan="1">84,348</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Ccbl1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Transiently lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">3.93<sup>a</sup>
</td><td align="left" colspan="1" rowspan="1">4.13<sup>a</sup>
</td><td char="." align="char" colspan="1" rowspan="1">28.3</td><td char="." align="char" colspan="1" rowspan="1">460</td><td char="." align="char" colspan="1" rowspan="1">311,844</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Col18a1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td char="." align="char" colspan="1" rowspan="1">51.6</td><td char="." align="char" colspan="1" rowspan="1">1204</td><td char="." align="char" colspan="1" rowspan="1">85,251</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Cyb5a</italic>
</td><td align="left" colspan="1" rowspan="1">Induced (H/W)</td><td align="left" colspan="1" rowspan="1">Higher in H/W</td><td align="left" colspan="1" rowspan="1">0.10<sup>a</sup>
</td><td align="left" colspan="1" rowspan="1">0.01<sup>b</sup>*</td><td char="." align="char" colspan="1" rowspan="1">59.8</td><td char="." align="char" colspan="1" rowspan="1">25,321</td><td char="." align="char" colspan="1" rowspan="1">64,001</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Derl1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">7.43</td><td align="left" colspan="1" rowspan="1">1.06<sup>a</sup>
</td><td char="." align="char" colspan="1" rowspan="1">19.6</td><td char="." align="char" colspan="1" rowspan="1">260</td><td char="." align="char" colspan="1" rowspan="1">362,912</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Eml4</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">0.32</td><td align="left" colspan="1" rowspan="1">0.94<sup>a</sup>
</td><td char="." align="char" colspan="1" rowspan="1">36.3</td><td char="." align="char" colspan="1" rowspan="1">539</td><td char="." align="char" colspan="1" rowspan="1">313,861</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Ern1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">3.47</td><td align="left" colspan="1" rowspan="1">0.05</td><td char="." align="char" colspan="1" rowspan="1">48.9</td><td char="." align="char" colspan="1" rowspan="1">136</td><td char="." align="char" colspan="1" rowspan="1">498,013</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Exoc3</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">2.28<sup>a</sup>
</td><td align="left" colspan="1" rowspan="1">4.42<sup>a</sup>
</td><td char="." align="char" colspan="1" rowspan="1">35.3</td><td char="." align="char" colspan="1" rowspan="1">780</td><td char="." align="char" colspan="1" rowspan="1">252,881</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Gfer</italic>
</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">0.62</td><td char="." align="char" colspan="1" rowspan="1">15.0</td><td char="." align="char" colspan="1" rowspan="1">74</td><td char="." align="char" colspan="1" rowspan="1">27,100</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Ghr</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">0.62</td><td align="left" colspan="1" rowspan="1">0.31</td><td char="." align="char" colspan="1" rowspan="1">56.4</td><td char="." align="char" colspan="1" rowspan="1">2303</td><td char="." align="char" colspan="1" rowspan="1">25,235</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Glud1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">3.07</td><td align="left" colspan="1" rowspan="1">1.22</td><td char="." align="char" colspan="1" rowspan="1">36.7</td><td char="." align="char" colspan="1" rowspan="1">1291</td><td char="." align="char" colspan="1" rowspan="1">24,399</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Ivns1abp</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">1.65</td><td align="left" colspan="1" rowspan="1">1.55</td><td char="." align="char" colspan="1" rowspan="1">16.4</td><td char="." align="char" colspan="1" rowspan="1">192</td><td char="." align="char" colspan="1" rowspan="1">289,089</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Lasp1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Variable</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.06</td><td char="." align="char" colspan="1" rowspan="1">30.0</td><td char="." align="char" colspan="1" rowspan="1">195</td><td char="." align="char" colspan="1" rowspan="1">29,278</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Neu1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">0.56</td><td align="left" colspan="1" rowspan="1">2.74</td><td char="." align="char" colspan="1" rowspan="1">56.9</td><td char="." align="char" colspan="1" rowspan="1">499</td><td char="." align="char" colspan="1" rowspan="1">24,591</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Pbld</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">0.47</td><td align="left" colspan="1" rowspan="1">0.56</td><td char="." align="char" colspan="1" rowspan="1">12.3</td><td char="." align="char" colspan="1" rowspan="1">2143</td><td char="." align="char" colspan="1" rowspan="1">171,564</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Pde2a</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">0.33</td><td align="left" colspan="1" rowspan="1">0.41</td><td char="." align="char" colspan="1" rowspan="1">40.7</td><td char="." align="char" colspan="1" rowspan="1">371</td><td char="." align="char" colspan="1" rowspan="1">81,743</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Perp</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">1.49</td><td align="left" colspan="1" rowspan="1">1.04</td><td char="." align="char" colspan="1" rowspan="1">28.4</td><td char="." align="char" colspan="1" rowspan="1">904</td><td char="." align="char" colspan="1" rowspan="1">292,949</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Pmm1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">1.76</td><td align="left" colspan="1" rowspan="1">1.01</td><td char="." align="char" colspan="1" rowspan="1">66.4</td><td char="." align="char" colspan="1" rowspan="1">372</td><td char="." align="char" colspan="1" rowspan="1">300,089</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Pomp</italic>
</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">None<sup>c</sup>
</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td char="." align="char" colspan="1" rowspan="1">20.5</td><td char="." align="char" colspan="1" rowspan="1">851</td><td char="." align="char" colspan="1" rowspan="1">288,455</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Psmb4</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Transiently lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">1.07</td><td align="left" colspan="1" rowspan="1">0.10*</td><td char="." align="char" colspan="1" rowspan="1">22.9</td><td char="." align="char" colspan="1" rowspan="1">394</td><td char="." align="char" colspan="1" rowspan="1">58,854</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Sdc1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">Transiently lower in L&#8211;E</td><td align="left" colspan="1" rowspan="1">0.46</td><td align="left" colspan="1" rowspan="1">0.27</td><td char="." align="char" colspan="1" rowspan="1">38.7</td><td char="." align="char" colspan="1" rowspan="1">513</td><td char="." align="char" colspan="1" rowspan="1">25,216</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Slco1a1</italic>
</td><td align="left" colspan="1" rowspan="1">Repressed</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">5.84</td><td align="left" colspan="1" rowspan="1">0.05</td><td char="." align="char" colspan="1" rowspan="1">35.6</td><td char="." align="char" colspan="1" rowspan="1">261</td><td char="." align="char" colspan="1" rowspan="1">50,572</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Srxn1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">Higher in L&#8211;E</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">0.60</td><td char="." align="char" colspan="1" rowspan="1">61.7</td><td char="." align="char" colspan="1" rowspan="1">252</td><td char="." align="char" colspan="1" rowspan="1">296,271</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Tpm1</italic>
</td><td align="left" colspan="1" rowspan="1">Induced</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">0.30</td><td align="left" colspan="1" rowspan="1">ND</td><td char="." align="char" colspan="1" rowspan="1">38.0</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">24,851</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Uvrag</italic>
</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">None</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td char="." align="char" colspan="1" rowspan="1">24.1</td><td char="." align="char" colspan="1" rowspan="1">117</td><td char="." align="char" colspan="1" rowspan="1">308,846</td></tr></tbody></table><table-wrap-foot><p>The column labelled &#8220;Absolute Difference&#8221; denotes the maximal absolute difference in mRNA counts (time course) between L&#8211;E and H/W rats. The &#8220;Difference as Percent&#8221; column is the &#8220;Absolute Difference&#8221; value as a per cent of the maximal TCDD-induced change for that gene. *Indicates a difference with <italic toggle="yes">p</italic>
<sub>adjusted</sub> value &lt;0.1 for between strain ED<sub>50</sub> values</p><p>
<sup>a</sup>ED<sub>50</sub> value significantly different from the prototypical AHR-regulated gene, <italic toggle="yes">Cyp1a1</italic> (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>)</p><p>
<sup>b</sup>Significant equivalence to <italic toggle="yes">Cyp1a1</italic>
</p><p>
<sup>c</sup>
<italic toggle="yes">Pomp</italic> shows two consecutive points that are significantly different between strains; however, the differences are not consistent&#8212;one time point has significantly reduced abundance, whereas the other shows significant induction. ND indicates that the ED50 could not be determined for that gene</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec11"><title>Sensitivity to TCDD</title><p>Of the 25 genes we examined, only <italic toggle="yes">Cyb5a</italic> (L&#8211;E, ED<sub>50</sub> 0.01) demonstrated TCDD sensitivity equivalent to the prototypic AHR-regulated gene, <italic toggle="yes">Cyp1a1</italic> [ED<sub>50</sub> 0.013 (H/W), 0.035 (L&#8211;E), (Watson et al. <xref ref-type="bibr" rid="CR98">2013</xref>)], while six genes displayed lower sensitivity. These genes [<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Ccbl1</italic> (L&#8211;E), <italic toggle="yes">Cyb5a</italic> (H/W), <italic toggle="yes">Derl1</italic> (L&#8211;E), <italic toggle="yes">Eml4</italic> (L&#8211;E) and <italic toggle="yes">Exoc3</italic>; Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, Fig.&#160;23] had an ED<sub>50</sub> significantly higher than that of <italic toggle="yes">Cyp1a1</italic>. Of these, <italic toggle="yes">Ackr3</italic> was the only gene with an ED<sub>50</sub> similar to the LD<sub>50</sub> of male L&#8211;E rats (8.62 vs. 17.7&#160;&#181;g/kg, respectively), while having an undetermined ED<sub>50</sub> in H/W.</p></sec></sec><sec id="Sec12"><title>Discussion</title><p>Previously, we identified 30 genes that exhibited concordant hepatic mRNA responses between two TCDD-sensitive rodent species following TCDD treatment, along with three genes that demonstrated divergent responses (Boutros et al. <xref ref-type="bibr" rid="CR5">2008</xref>). These 33 genes are candidate mediators of TCDD-induced hepatotoxicity in TCDD-sensitive rodents. Liver was selected for study because numerous studies show extensive biochemical and pathologic changes in liver following dioxin exposure (Forgacs et al. <xref ref-type="bibr" rid="CR19">2012</xref>; Pohjanvirta et al. <xref ref-type="bibr" rid="CR58">1989</xref>, <xref ref-type="bibr" rid="CR59">1990</xref>; Viluksela et al. <xref ref-type="bibr" rid="CR92">2000</xref>, <xref ref-type="bibr" rid="CR91">1999</xref>). Further, unlike other potential target organs such as white adipose tissue or hypothalamus where few mRNAs are altered by TCDD exposure (Houlahan et al. <xref ref-type="bibr" rid="CR27">2015a</xref>, <xref ref-type="bibr" rid="CR28">b</xref>), hundreds to thousands of rat liver genes are modulated by the activated AHR following TCDD exposure (Boutros et al. <xref ref-type="bibr" rid="CR6">2011</xref>; Boverhof et al. <xref ref-type="bibr" rid="CR7">2006</xref>; Fletcher et al. <xref ref-type="bibr" rid="CR18">2005</xref>; Franc et al. <xref ref-type="bibr" rid="CR21">2008</xref>; Vezina et al. <xref ref-type="bibr" rid="CR90">2004</xref>; Yao et al. <xref ref-type="bibr" rid="CR101">2012</xref>). Our goal was to prioritize the 25 non-&#8220;AHR-core&#8221; genes of this cohort for further mechanistic investigation. Rat strains with striking differences in susceptibility to TCDD toxicities were selected: H/W rats are essentially unaffected by doses that are lethal to L&#8211;E rats (Tuomisto et al. <xref ref-type="bibr" rid="CR83">1999</xref>). Inter-strain differences in the abundance profiles for a specific mRNA that occur before or at the onset of toxicity may indicate genes mechanistically involved in TCDD-induced type II toxicity. Further, genes involved in L&#8211;E-specific toxicity might be expected to be more sensitive to TCDD treatment, having a lower ED<sub>50</sub> for these genes in L&#8211;E than in H/W animals, or the genes may only be responsive in L&#8211;E. It has been shown that the earliest manifestations of toxicity occur rapidly, with TCDD-induced weight loss and changes in blood chemistry measurable within 24&#160;h (Linden et al. <xref ref-type="bibr" rid="CR40">2014</xref>). Interestingly, the onset of biochemical or physiological changes in response to TCDD occurs at a time very close to that observed for the &#8220;biphasic&#8221; changes in mRNA abundance suggested for <italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Ccbl1</italic>, <italic toggle="yes">Ern1</italic>, <italic toggle="yes">Exoc3</italic>, <italic toggle="yes">Neu1</italic>, <italic toggle="yes">Pde2a</italic>, <italic toggle="yes">Perp</italic>, <italic toggle="yes">Pmm1</italic> and <italic toggle="yes">Sxrn1</italic>.</p><p>Of the 25 genes examined, eight are unlikely to be directly involved in type II toxic responses to TCDD, since they exhibited similar responses to TCDD in both TCDD-sensitive and TCDD-resistant strains throughout the time course study and at all doses tested (<italic toggle="yes">Gfer</italic>, <italic toggle="yes">Ivns1abp</italic>, <italic toggle="yes">Pbld</italic>, <italic toggle="yes">Pde2a</italic>, <italic toggle="yes">Pomp</italic>, <italic toggle="yes">Slco1a1</italic>, <italic toggle="yes">Tpm1</italic> and <italic toggle="yes">Uvrag</italic> Fig. S2&#8211;S9). The remaining 17 displayed some degree of inter-strain differential mRNA abundance following TCDD exposure. Most of these demonstrated enhanced or exaggerated effects in response to TCDD exposure in TCDD-sensitive L&#8211;E rats. Only <italic toggle="yes">Cyb5a</italic> (one of the four genes that displayed a significant, prolonged inter-strain difference) had an enhanced response in the TCDD-resistant H/W liver, with an ~twofold up-regulation beginning early (6 to 10&#160;h) after exposure, as compared to essentially no change in L&#8211;E liver (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). This H/W-specific gene modulation had previously been observed for <italic toggle="yes">Cyb5a</italic> and other six genes (Boutros et al. <xref ref-type="bibr" rid="CR6">2011</xref>). It is possible that <italic toggle="yes">Cyb5a</italic> and other H/W-specific gene responses to TCDD play a protective role, ameliorating toxic outcomes. Comparison of the genomic DNA sequences for H/W and L&#8211;E rat did not identify any differences in AHREs within 3 kilobases of the transcriptional start site for any of the genes (Boutros, PC and Prokopec SD, in preparation). Of note, <italic toggle="yes">Cyb5a</italic> has recently been shown to be involved in the kynurenine pathway, its gene product acting as the major reducing agent of indoleamine 2,3-dioxygenase (IDO), the first and rate-limiting step (Maghzal et al. <xref ref-type="bibr" rid="CR43">2008</xref>). Altered tryptophan metabolism following TCDD treatment with increased circulating levels of tryptophan in TCDD-sensitive rat strains including L&#8211;E and concomitant decreases in tryptophan dioxygenase activity in rat liver has been observed (Unkila et al. <xref ref-type="bibr" rid="CR84">1994</xref>, <xref ref-type="bibr" rid="CR85">1995</xref>, <xref ref-type="bibr" rid="CR86">1998</xref>, <xref ref-type="bibr" rid="CR87">1999</xref>; Weber et al. <xref ref-type="bibr" rid="CR99">1994</xref>). Further, <italic toggle="yes">Cyb5a</italic> has been shown to play a role in promoting autophagy in pancreatic cancer cells (Giovannetti et al. <xref ref-type="bibr" rid="CR22">2014</xref>). Promotion of autophagy has also been shown to reduce steatohepatitis and fibrosis in mouse liver (Lodder et al. <xref ref-type="bibr" rid="CR42">2015</xref>; Zhong et al. <xref ref-type="bibr" rid="CR103">2015</xref>), perhaps representing a mechanism by which <italic toggle="yes">Cyb5a</italic> protects H/W rats.</p><p>Following TCDD treatment, liver <italic toggle="yes">Ghr</italic> (growth hormone receptor) is lower at four time points, separated by a single non-significant difference at 19&#160;h in TCDD-sensitive L&#8211;E when compared to that observed in TCDD-resistant H/W (Fig. S15). This gene could be involved in both early and late responses to TCDD exposure. AHR activation leads to suppression of <italic toggle="yes">Ghr</italic> mRNA levels in livers of TCDD-sensitive mice (Nukaya et al. <xref ref-type="bibr" rid="CR51">2004</xref>). Reduced <italic toggle="yes">Ghr</italic> mRNA abundance in TCDD-sensitive L&#8211;E rats may play a significant role in the pathogenesis of many well-known TCDD-induced toxic outcomes. Following a lethal dose of TCDD, L&#8211;E rat liver undergoes accumulation of fat and infiltration of inflammatory cells (steatohepatitis), while this does not occur in H/W rats given the same dose of TCDD (Pohjanvirta et al. <xref ref-type="bibr" rid="CR58">1989</xref>, <xref ref-type="bibr" rid="CR59">1990</xref>). Similarly, reduction in growth hormone signalling by liver-specific knockout of <italic toggle="yes">Stat5</italic> leads to steatohepatitis, glucose intolerance, late onset obesity, impaired liver regeneration and insulin resistance (Baik et al. <xref ref-type="bibr" rid="CR1">2011</xref>). Liver-specific knockout of <italic toggle="yes">Ghr</italic> in mice recapitulated the <italic toggle="yes">Stat5</italic> knockout phenotype and also led to non-alcoholic fatty liver disease, fibrosis and hepatocellular carcinoma (Fan et al. <xref ref-type="bibr" rid="CR16">2014</xref>). Signalling through the GHR also directly affects metabolism and insulin secretion (Strobl and Thomas <xref ref-type="bibr" rid="CR75">1994</xref>), as well as sex steroid metabolism (Baik et al. <xref ref-type="bibr" rid="CR1">2011</xref>), immune function and apoptosis (Savino et al. <xref ref-type="bibr" rid="CR67">2002</xref>).</p><p>The remaining three genes with prolonged inter-strain differences produce proteins involved in metabolic processes, angiogenesis, cytokine response, liver survival, liver repair and regeneration. The first of these, <italic toggle="yes">Glud1</italic> (glutamate dehydrogenase 1), is a mitochondrial enzyme that catalyses the reversible conversion of glutamate to &#945;-ketoglutarate and regulates several important metabolic and neurological pathways. The mRNA abundance of <italic toggle="yes">Glud1</italic> is reduced in both strains but to a greater extent in TCDD-sensitive L&#8211;E rats. Glutamate plays a key role in regulation of energy homoeostasis in an organ-specific manner (reviewed by Karaca et al. <xref ref-type="bibr" rid="CR33">2011</xref>). In pancreatic islet cells for instance, decreased <italic toggle="yes">Glud1</italic> activity reduced insulin release, leading to organism-wide metabolic alterations. Reduced plasma insulin levels following TCDD treatment in Sprague&#8211;Dawley rats have been observed (Gorski et al. <xref ref-type="bibr" rid="CR24">1988</xref>; Gorski and Rozman <xref ref-type="bibr" rid="CR23">1987</xref>).</p><p>
<italic toggle="yes">Col18a1</italic> mRNA abundance was significantly lower in L&#8211;E rat at early (3&#8211;10&#160;h, Fig. S3) and late time points following TCDD insult. It will be interesting to determine whether the decreased mRNA abundance is correlated with decreased amounts of both mature COL18A1 and/or decreased amounts of active peptide domains. These early differences between L&#8211;E and H/W may indicate that <italic toggle="yes">Col18a1</italic> is involved in the early stages of TCDD hepatotoxicity, while the late difference may indicate it also is involved in TCDD-induced cancer or other delayed toxicities (Viluksela et al. <xref ref-type="bibr" rid="CR92">2000</xref>). COL18A1 mutations that lead to deficiency in its cleavage product, endostatin, have been shown to lead to cancer (Mahajan et al. <xref ref-type="bibr" rid="CR44">2010</xref>). Interestingly, COL18A1 contains amino terminal domains which, upon proteolytic cleavage, inhibit blood vessel formation (Zhuo et al. <xref ref-type="bibr" rid="CR104">2011</xref>), reduce cellular proliferation (Zhang et al. <xref ref-type="bibr" rid="CR102">2012</xref>) and block WNT signalling (Lavergne et al. <xref ref-type="bibr" rid="CR36">2011</xref>; Quelard et al. <xref ref-type="bibr" rid="CR64">2008</xref>; Seppinen and Pihlajaniemi <xref ref-type="bibr" rid="CR68">2011</xref>). Importantly, COL18A1 is an essential survival factor following acute liver toxicity from CCl<sub>4</sub> (Duncan et al. <xref ref-type="bibr" rid="CR14">2013</xref>).</p><p>
<italic toggle="yes">Ackr3</italic> displays the largest and most prolonged change that we observed in L&#8211;E rat (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, all time points and maximally &gt;16-fold difference from H/W rat). Interestingly, the ED<sub>50</sub> for <italic toggle="yes">Ackr3</italic> in L&#8211;E rats is ~8.3, while the there was no change observed in H/W rat for any doses tested at 19&#160;h. Since <italic toggle="yes">Ackr3</italic> responds only in the sensitive L&#8211;E strain, has an early response and exhibits an ED<sub>50</sub>, similar to the LD<sub>50</sub> for TCDD in L&#8211;E rats (male ~17.7&#160;&#181;g/kg), it closely resembles the expected profile for genes causative of TCDD toxicity. It has been shown that the ED<sub>50</sub> values for toxic outcomes following TCDD exposure, such as thymic atrophy and wasting syndrome, are similar to the LD<sub>50</sub> values in Sprague&#8211;Dawley rats (Hanberg et al. <xref ref-type="bibr" rid="CR26">1989</xref>). Ackr3 binds to cytokines SDF-1 and ITAC, and has been implicated in cellular migration and invasion (Naumann et al. <xref ref-type="bibr" rid="CR50">2010</xref>; Tarnowski et al. <xref ref-type="bibr" rid="CR78">2010</xref>). <italic toggle="yes">Ackr3</italic> has also been implicated in hypoxia response, tumour development, cell growth, cell survival and adhesion (Burns et al. <xref ref-type="bibr" rid="CR9">2006</xref>; Hu et al. <xref ref-type="bibr" rid="CR29">2010</xref>; Liu et al. <xref ref-type="bibr" rid="CR41">2010</xref>; Staton et al. <xref ref-type="bibr" rid="CR73">2011</xref>; Sun et al. <xref ref-type="bibr" rid="CR76">2010</xref>). Further, it plays a role in the brain and may be involved in modulation of anxiety and other behaviour (Guyon <xref ref-type="bibr" rid="CR25">2014</xref>; Ikeda et al. <xref ref-type="bibr" rid="CR31">2013</xref>). Recently, <italic toggle="yes">Ackr3</italic> has been identified as a liver injury-inducible liver sinusoidal endothelial cell (LSEC)-specific SDF-1 receptor (Ding et al. <xref ref-type="bibr" rid="CR12">2014</xref>). Induction of <italic toggle="yes">Ackr3</italic> in LSECs stimulates liver regeneration and reduces fibrosis. This is unexpected since other reports have shown that TCDD exposure increases expression of molecular markers of fibrosis in mice (Pierre et al. <xref ref-type="bibr" rid="CR56">2014</xref>). Activated <italic toggle="yes">Ackr3</italic> has been shown to increase uptake of VLDL and cholesterol into adipose tissue, reducing circulating levels (Li et al. <xref ref-type="bibr" rid="CR38">2014</xref>). It is expressed at very low levels in normal hepatic tissue, but is highly expressed in murine hepatocellular carcinoma, predominantly in epithelial cells (Monnier et al. <xref ref-type="bibr" rid="CR49">2011</xref>). <italic toggle="yes">Ackr3</italic> inhibition or inactivation reduces head and neck tumour growth and increases survival of mice with brain cancer (Maussang et al. <xref ref-type="bibr" rid="CR46">2013</xref>; Walters et al. <xref ref-type="bibr" rid="CR97">2014</xref>).</p><p>Of the 33 genes identified in our previous comparison of two TCDD-sensitive rodent species, mice and rats, we analysed here the 25 non-&#8220;AHR-core&#8221; genes in-depth to further characterize candidate mediators of TCDD toxicity. Of these, four genes displayed an inter-strain difference that persisted for 240&#160;h or more (<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Col18a1</italic> and <italic toggle="yes">Glud1</italic>) with significantly different mRNA responses in livers of TCDD-resistant H/W versus TCDD-sensitive L&#8211;E rats. Since L&#8211;E rats are susceptible to TCDD-induced toxicities, whereas H/W rats are essentially refractory to them; these genes may play essential roles in the onset of toxicity. This study takes a key step towards identification of the specific genes and metabolic pathways which underlie toxic outcomes induced by TCDD by showing that eight TCDD-altered genes are unlikely to be involved in TCDD toxicity (<italic toggle="yes">Gfer</italic>, <italic toggle="yes">Ivns1abp</italic>, <italic toggle="yes">Pbld</italic>, <italic toggle="yes">Pde2a</italic>, <italic toggle="yes">Pomp</italic>, <italic toggle="yes">Slco1a1</italic>, <italic toggle="yes">Tpm1</italic> and <italic toggle="yes">Uvrag</italic>), while identifying four genes (<italic toggle="yes">Ackr3</italic>, <italic toggle="yes">Cyb5a</italic>, <italic toggle="yes">Col18a1</italic> and <italic toggle="yes">Glud1</italic>) that could play a key role in toxic outcomes. Future studies will be required to determine whether the reported changes in mRNA abundance lead to downstream changes in protein abundance, enzyme activities or sub-cellular location.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec13"><p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM1_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary material 1 (XLSX 18 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary material 2 (PDF 1091 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM3_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary material 3 (XLSX 775 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM4_ESM.txt" position="float" orientation="portrait"><caption><p>Supplementary material 4 (TXT 11 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM5_ESM.txt" position="float" orientation="portrait"><caption><p>Supplementary material 5 (TXT 10 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM6_ESM.txt" position="float" orientation="portrait"><caption><p>Supplementary material 6 (TXT 27 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM7_ESM.txt" position="float" orientation="portrait"><caption><p>Supplementary material 7 (TXT 45 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM8_ESM.file" position="float" orientation="portrait"><caption><p>Supplementary material 8 (FILE 6 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM9_ESM.txt" position="float" orientation="portrait"><caption><p>Supplementary material 9 (TXT 4 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM10_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary material 10 (XLSX 17 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM11_ESM.xls" position="float" orientation="portrait"><caption><p>Supplementary material 11 (XLS 635 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="204_2016_1720_MOESM12_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary material 12 (PDF 4277 kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><ack><p>This work was supported by the Canadian Institutes of Health Research (Grant MOP-57903 to ABO and PCB), the Academy of Finland (Grant Numbers 123345 and 261232 to RP) and the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. PCB is a CIHR New Investigator and a Terry Fox Research Institute New Investigator. The study sponsors had no role in study design; in data collection, analysis and interpretation; in the report writing; nor in the decision to submit the paper for publication. The authors thank Daryl Waggott, Christine P&#8217;ng, Alexander Wu, Arja Moilanen and Susanna Lukkarinen for technical assistance and all members of the Boutros lab for insightful discussions.</p></ack><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p>ABO has served as a paid consultant to The Dow Chemical Company as a member of their Dioxin Scientific Advisory Board. Other authors declare that they have no conflicts of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baik</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>JH</given-names></name><name name-style="western"><surname>Hennighausen</surname><given-names>L</given-names></name></person-group><article-title>Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism</article-title><source>Ann N Y Acad Sci</source><year>2011</year><volume>1229</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">21793836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1749-6632.2011.06100.x</pub-id><pub-id pub-id-type="pmcid">PMC3427656</pub-id></element-citation></ref><ref id="CR2"><mixed-citation publication-type="other">Beckstead JW (2008) Tests of statistical difference and equivalence. In: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://personal.health.usf.edu/jbeckste/equiv.xls">http://personal.health.usf.edu/jbeckste/equiv.xls</ext-link>&#8206; Accessed June 26 2013</mixed-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Non-carcinogenic effects of TCDD in animals</article-title><source>Food Addit Contam</source><year>2000</year><volume>17</volume><issue>4</issue><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">10912242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/026520300283351</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>MM</given-names></name><name name-style="western"><surname>Blair</surname><given-names>PC</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AM</given-names></name><name name-style="western"><surname>Harris</surname><given-names>MW</given-names></name></person-group><article-title>Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6&#160;J mice congenic at the Ah locus</article-title><source>Fundam Appl Toxicol</source><year>1990</year><volume>15</volume><issue>1</issue><fpage>186</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">2373298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0272-0590(90)90175-j</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name><name name-style="western"><surname>Yan</surname><given-names>R</given-names></name><name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name></person-group><article-title>Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse</article-title><source>BMC Genom</source><year>2008</year><volume>9</volume><fpage>419</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2164-9-419</pub-id><pub-id pub-id-type="pmcid">PMC2559853</pub-id><pub-id pub-id-type="pmid">18796159</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name><name name-style="western"><surname>Yao</surname><given-names>CQ</given-names></name><name name-style="western"><surname>Watson</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity</article-title><source>Toxicol Appl Pharmacol</source><year>2011</year><volume>251</volume><issue>2</issue><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">21215274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2010.12.010</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boverhof</surname><given-names>DR</given-names></name><name name-style="western"><surname>Burgoon</surname><given-names>LD</given-names></name><name name-style="western"><surname>Tashiro</surname><given-names>C</given-names></name><etal/></person-group><article-title>Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice</article-title><source>Toxicol Sci</source><year>2006</year><volume>94</volume><issue>2</issue><fpage>398</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">16960034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfl100</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunger</surname><given-names>MK</given-names></name><name name-style="western"><surname>Moran</surname><given-names>SM</given-names></name><name name-style="western"><surname>Glover</surname><given-names>E</given-names></name><etal/></person-group><article-title>Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>20</issue><fpage>17767</fpage><lpage>17774</lpage><pub-id pub-id-type="pmid">12621046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M209594200</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>JM</given-names></name><name name-style="western"><surname>Summers</surname><given-names>BC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><issue>9</issue><fpage>2201</fpage><lpage>2213</lpage><pub-id pub-id-type="pmid">16940167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20052144</pub-id><pub-id pub-id-type="pmcid">PMC2118398</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlson</surname><given-names>EA</given-names></name><name name-style="western"><surname>McCulloch</surname><given-names>C</given-names></name><name name-style="western"><surname>Koganti</surname><given-names>A</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>SB</given-names></name><name name-style="western"><surname>Sutter</surname><given-names>TR</given-names></name><name name-style="western"><surname>Silkworth</surname><given-names>JB</given-names></name></person-group><article-title>Divergent transcriptomic responses to aryl hydrocarbon receptor agonists between rat and human primary hepatocytes</article-title><source>Toxicol Sci</source><year>2009</year><volume>112</volume><issue>1</issue><fpage>257</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">19692669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfp200</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Consonni</surname><given-names>D</given-names></name><name name-style="western"><surname>Pesatori</surname><given-names>AC</given-names></name><name name-style="western"><surname>Zocchetti</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25&#160;years of follow-up</article-title><source>Am J Epidemiol</source><year>2008</year><volume>167</volume><issue>7</issue><fpage>847</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">18192277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwm371</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>BS</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lis</surname><given-names>R</given-names></name><etal/></person-group><article-title>Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis</article-title><source>Nature</source><year>2014</year><volume>505</volume><issue>7481</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">24256728</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12681</pub-id><pub-id pub-id-type="pmcid">PMC4142699</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domingo</surname><given-names>JL</given-names></name><name name-style="western"><surname>Bocio</surname><given-names>A</given-names></name></person-group><article-title>Levels of PCDD/PCDFs and PCBs in edible marine species and human intake: a literature review</article-title><source>Environ Int</source><year>2007</year><volume>33</volume><issue>3</issue><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">17270272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envint.2006.12.004</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>MB</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Tanjore</surname><given-names>H</given-names></name><etal/></person-group><article-title>Type XVIII collagen is essential for survival during acute liver injury in mice</article-title><source>Dis Model Mech</source><year>2013</year><volume>6</volume><issue>4</issue><fpage>942</fpage><lpage>951</lpage><pub-id pub-id-type="pmid">23580202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/dmm.011577</pub-id><pub-id pub-id-type="pmcid">PMC3701214</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edgar</surname><given-names>R</given-names></name><name name-style="western"><surname>Domrachev</surname><given-names>M</given-names></name><name name-style="western"><surname>Lash</surname><given-names>AE</given-names></name></person-group><article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><issue>1</issue><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">11752295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/30.1.207</pub-id><pub-id pub-id-type="pmcid">PMC99122</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fang</surname><given-names>X</given-names></name><name name-style="western"><surname>Tajima</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice</article-title><source>Front Endocrinol (Lausanne)</source><year>2014</year><volume>5</volume><fpage>218</fpage><pub-id pub-id-type="pmid">25566190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2014.00218</pub-id><pub-id pub-id-type="pmcid">PMC4270248</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Salguero</surname><given-names>PM</given-names></name><name name-style="western"><surname>Hilbert</surname><given-names>DM</given-names></name><name name-style="western"><surname>Rudikoff</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><article-title>Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity</article-title><source>Toxicol Appl Pharmacol</source><year>1996</year><volume>140</volume><issue>1</issue><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">8806883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1996.0210</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fletcher</surname><given-names>N</given-names></name><name name-style="western"><surname>Wahlstrom</surname><given-names>D</given-names></name><name name-style="western"><surname>Lundberg</surname><given-names>R</given-names></name><etal/></person-group><article-title>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study</article-title><source>Toxicol Appl Pharmacol</source><year>2005</year><volume>207</volume><issue>1</issue><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16054898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2004.12.003</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forgacs</surname><given-names>AL</given-names></name><name name-style="western"><surname>Kent</surname><given-names>MN</given-names></name><name name-style="western"><surname>Makley</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver</article-title><source>Toxicological sciences: an official journal of the Society of Toxicology</source><year>2012</year><volume>125</volume><issue>1</issue><fpage>41</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21964420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfr262</pub-id><pub-id pub-id-type="pmcid">PMC3243745</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forgacs</surname><given-names>AL</given-names></name><name name-style="western"><surname>Dere</surname><given-names>E</given-names></name><name name-style="western"><surname>Angrish</surname><given-names>MM</given-names></name><name name-style="western"><surname>Zacharewski</surname><given-names>TR</given-names></name></person-group><article-title>Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes</article-title><source>Toxicol Sci</source><year>2013</year><volume>133</volume><issue>1</issue><fpage>54</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">23418086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kft028</pub-id><pub-id pub-id-type="pmcid">PMC3627554</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Franc</surname><given-names>MA</given-names></name><name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats</article-title><source>Arch Toxicol</source><year>2008</year><volume>82</volume><issue>11</issue><fpage>809</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">18465118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-008-0303-0</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giovannetti</surname><given-names>E</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Avan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Role of CYB5A in pancreatic cancer prognosis and autophagy modulation</article-title><source>J Natl Cancer Inst</source><year>2014</year><volume>106</volume><issue>1</issue><fpage>djt346</fpage><pub-id pub-id-type="pmid">24301457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djt346</pub-id><pub-id pub-id-type="pmcid">PMC3906994</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorski</surname><given-names>JR</given-names></name><name name-style="western"><surname>Rozman</surname><given-names>K</given-names></name></person-group><article-title>Dose-response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats</article-title><source>Toxicology</source><year>1987</year><volume>44</volume><issue>3</issue><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">3554617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(87)90031-x</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorski</surname><given-names>JR</given-names></name><name name-style="western"><surname>Muzi</surname><given-names>G</given-names></name><name name-style="western"><surname>Weber</surname><given-names>LW</given-names></name><etal/></person-group><article-title>Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title><source>Toxicol Pathol</source><year>1988</year><volume>16</volume><issue>3</issue><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">3057589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/019262338801600301</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guyon</surname><given-names>A</given-names></name></person-group><article-title>CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems</article-title><source>Front Cell Neurosci</source><year>2014</year><volume>8</volume><fpage>65</fpage><pub-id pub-id-type="pmid">24639628</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fncel.2014.00065</pub-id><pub-id pub-id-type="pmcid">PMC3944789</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Hakansson</surname><given-names>H</given-names></name><name name-style="western"><surname>Ahlborg</surname><given-names>UG</given-names></name></person-group><article-title>&#8220;ED50&#8221; values for TCDD-induced reduction of body weight gain, liver enlargement, and thymic atrophy in Hartley guinea pigs, Sprague-Dawley rats, C57BL/6 mice, and golden Syrian hamsters</article-title><source>Chemosphere</source><year>1989</year><volume>19</volume><issue>1&#8211;6</issue><fpage>813</fpage><lpage>816</lpage></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houlahan</surname><given-names>KE</given-names></name><name name-style="western"><surname>Prokopec</surname><given-names>SD</given-names></name><name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name><etal/></person-group><article-title>Transcriptional profiling of rat hypothalamus response to 2,3,7,8-tetrachlorodibenzo-rho-dioxin</article-title><source>Toxicology</source><year>2015</year><volume>328</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">25529477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2014.12.016</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houlahan</surname><given-names>KE</given-names></name><name name-style="western"><surname>Prokopec</surname><given-names>SD</given-names></name><name name-style="western"><surname>Sun</surname><given-names>RX</given-names></name><etal/></person-group><article-title>Transcriptional profiling of rat white adipose tissue response to 2,3,7,8-tetrachlorodibenzo-rho-dioxin</article-title><source>Toxicol Appl Pharmacol</source><year>2015</year><volume>288</volume><issue>2</issue><fpage>223</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">26232522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2015.07.018</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Owens</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer</article-title><source>Neoplasia</source><year>2010</year><volume>12</volume><issue>10</issue><fpage>826</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">20927321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1593/neo.10586</pub-id><pub-id pub-id-type="pmcid">PMC2950332</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ihaka</surname><given-names>R</given-names></name><name name-style="western"><surname>Gentleman</surname><given-names>R</given-names></name></person-group><article-title>R: a language for data analysis and graphics</article-title><source>J Comput Graph Stat</source><year>1996</year><volume>5</volume><fpage>16</fpage></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikeda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kumagai</surname><given-names>H</given-names></name><name name-style="western"><surname>Skach</surname><given-names>A</given-names></name><name name-style="western"><surname>Sato</surname><given-names>M</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>M</given-names></name></person-group><article-title>Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior</article-title><source>Cell</source><year>2013</year><volume>155</volume><issue>6</issue><fpage>1323</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">24315101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2013.10.052</pub-id><pub-id pub-id-type="pmcid">PMC3934808</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>M</given-names></name><name name-style="western"><surname>Zaretskaya</surname><given-names>I</given-names></name><name name-style="western"><surname>Raytselis</surname><given-names>Y</given-names></name><name name-style="western"><surname>Merezhuk</surname><given-names>Y</given-names></name><name name-style="western"><surname>McGinnis</surname><given-names>S</given-names></name><name name-style="western"><surname>Madden</surname><given-names>TL</given-names></name></person-group><article-title>NCBI BLAST: a better web interface</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><issue>Web Server issue</issue><fpage>W5</fpage><lpage>W9</lpage><pub-id pub-id-type="pmid">18440982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkn201</pub-id><pub-id pub-id-type="pmcid">PMC2447716</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karaca</surname><given-names>M</given-names></name><name name-style="western"><surname>Frigerio</surname><given-names>F</given-names></name><name name-style="western"><surname>Maechler</surname><given-names>P</given-names></name></person-group><article-title>From pancreatic islets to central nervous system, the importance of glutamate dehydrogenase for the control of energy homeostasis</article-title><source>Neurochem Int</source><year>2011</year><volume>59</volume><issue>4</issue><fpage>510</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">21600947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuint.2011.03.024</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kewley</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Whitelaw</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chapman-Smith</surname><given-names>A</given-names></name></person-group><article-title>The mammalian basic helix-loop-helix/PAS family of transcriptional regulators</article-title><source>Int J Biochem Cell Biol</source><year>2004</year><volume>36</volume><issue>2</issue><fpage>189</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">14643885</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1357-2725(03)00211-5</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilkenny</surname><given-names>C</given-names></name><name name-style="western"><surname>Browne</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Cuthill</surname><given-names>IC</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>M</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</article-title><source>PLoS Biol</source><year>2010</year><volume>8</volume><issue>6</issue><fpage>e1000412</fpage><pub-id pub-id-type="pmid">20613859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.1000412</pub-id><pub-id pub-id-type="pmcid">PMC2893951</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavergne</surname><given-names>E</given-names></name><name name-style="western"><surname>Hendaoui</surname><given-names>I</given-names></name><name name-style="western"><surname>Coulouarn</surname><given-names>C</given-names></name><etal/></person-group><article-title>Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active beta-catenin</article-title><source>Oncogene</source><year>2011</year><volume>30</volume><issue>4</issue><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">20856206</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/onc.2010.432</pub-id><pub-id pub-id-type="pmcid">PMC3501789</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>CF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>F</given-names></name></person-group><article-title>Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6&#160;J mice</article-title><source>Biol Chem</source><year>2010</year><volume>391</volume><issue>10</issue><fpage>1205</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">20707612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/BC.2010.126</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Penfold</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue</article-title><source>Circulation</source><year>2014</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.113.006840</pub-id><pub-id pub-id-type="pmid">24374972</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindebro</surname><given-names>MC</given-names></name><name name-style="western"><surname>Poellinger</surname><given-names>L</given-names></name><name name-style="western"><surname>Whitelaw</surname><given-names>ML</given-names></name></person-group><article-title>Protein-protein interaction via PAS domains: role of the PAS domain in positive and negative regulation of the bHLH/PAS dioxin receptor-Arnt transcription factor complex</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><issue>14</issue><fpage>3528</fpage><lpage>3539</lpage><pub-id pub-id-type="pmid">7628454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1995.tb07359.x</pub-id><pub-id pub-id-type="pmcid">PMC394421</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linden</surname><given-names>J</given-names></name><name name-style="western"><surname>Lensu</surname><given-names>S</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name></person-group><article-title>Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain</article-title><source>Int J Mol Sci</source><year>2014</year><volume>15</volume><issue>8</issue><fpage>13938</fpage><lpage>13966</lpage><pub-id pub-id-type="pmid">25119860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms150813938</pub-id><pub-id pub-id-type="pmcid">PMC4159833</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Xue</surname><given-names>W</given-names></name><name name-style="western"><surname>Ge</surname><given-names>G</given-names></name><etal/></person-group><article-title>Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs</article-title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>401</volume><issue>4</issue><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">20869949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2010.09.076</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodder</surname><given-names>J</given-names></name><name name-style="western"><surname>Denaes</surname><given-names>T</given-names></name><name name-style="western"><surname>Chobert</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Macrophage autophagy protects against liver fibrosis in mice</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><issue>8</issue><fpage>1280</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">26061908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2015.1058473</pub-id><pub-id pub-id-type="pmcid">PMC4590651</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maghzal</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>SR</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>NH</given-names></name><name name-style="western"><surname>Stocker</surname><given-names>R</given-names></name></person-group><article-title>Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><issue>18</issue><fpage>12014</fpage><lpage>12025</lpage><pub-id pub-id-type="pmid">18299324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M710266200</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahajan</surname><given-names>VB</given-names></name><name name-style="western"><surname>Olney</surname><given-names>AH</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>P</given-names></name><etal/></person-group><article-title>Collagen XVIII mutation in Knobloch syndrome with acute lymphoblastic leukemia</article-title><source>Am J Med Genet A</source><year>2010</year><volume>152A</volume><issue>11</issue><fpage>2875</fpage><lpage>2879</lpage><pub-id pub-id-type="pmid">20799329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ajmg.a.33621</pub-id><pub-id pub-id-type="pmcid">PMC2965270</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumura</surname><given-names>F</given-names></name></person-group><article-title>The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects</article-title><source>Biochem Pharmacol</source><year>2009</year><volume>77</volume><issue>4</issue><fpage>608</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">18996358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2008.10.013</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maussang</surname><given-names>D</given-names></name><name name-style="western"><surname>Mujic-Delic</surname><given-names>A</given-names></name><name name-style="western"><surname>Descamps</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>41</issue><fpage>29562</fpage><lpage>29572</lpage><pub-id pub-id-type="pmid">23979133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M113.498436</pub-id><pub-id pub-id-type="pmcid">PMC3795254</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mimura</surname><given-names>J</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><etal/></person-group><article-title>Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor</article-title><source>Genes Cells</source><year>1997</year><volume>2</volume><issue>10</issue><fpage>645</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">9427285</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2443.1997.1490345.x</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name></person-group><article-title>Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities</article-title><source>BMC Genom</source><year>2010</year><volume>11</volume><fpage>263</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2164-11-263</pub-id><pub-id pub-id-type="pmcid">PMC2881023</pub-id><pub-id pub-id-type="pmid">20420666</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monnier</surname><given-names>J</given-names></name><name name-style="western"><surname>Boissan</surname><given-names>M</given-names></name><name name-style="western"><surname>L&#8217;Helgoualc&#8217;h</surname><given-names>A</given-names></name><etal/></person-group><article-title>CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells</article-title><source>Eur J Cancer</source><year>2011</year><pub-id pub-id-type="pmid">21778049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2011.06.044</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naumann</surname><given-names>U</given-names></name><name name-style="western"><surname>Cameroni</surname><given-names>E</given-names></name><name name-style="western"><surname>Pruenster</surname><given-names>M</given-names></name><etal/></person-group><article-title>CXCR7 functions as a scavenger for CXCL12 and CXCL11</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><issue>2</issue><fpage>e9175</fpage><pub-id pub-id-type="pmid">20161793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0009175</pub-id><pub-id pub-id-type="pmcid">PMC2820091</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nukaya</surname><given-names>M</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Kamataki</surname><given-names>T</given-names></name></person-group><article-title>Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice</article-title><source>FEBS Lett</source><year>2004</year><volume>558</volume><issue>1&#8211;3</issue><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">14759523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0014-5793(03)01528-X</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nukaya</surname><given-names>M</given-names></name><name name-style="western"><surname>Walisser</surname><given-names>JA</given-names></name><name name-style="western"><surname>Moran</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>GD</given-names></name><name name-style="western"><surname>Bradfield</surname><given-names>CA</given-names></name></person-group><article-title>Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver</article-title><source>Toxicol Sci</source><year>2010</year><volume>118</volume><issue>2</issue><fpage>554</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">20935161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfq305</pub-id><pub-id pub-id-type="pmcid">PMC2984536</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name></person-group><article-title>An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI</article-title><source>Toxicol Sci</source><year>2007</year><volume>98</volume><issue>1</issue><fpage>5</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">17569696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfm096</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Vella</surname><given-names>LM</given-names></name><name name-style="western"><surname>Harper</surname><given-names>PA</given-names></name></person-group><article-title>Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene</article-title><source>Mol Pharmacol</source><year>1989</year><volume>35</volume><issue>6</issue><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">2543914</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pesatori</surname><given-names>AC</given-names></name><name name-style="western"><surname>Consonni</surname><given-names>D</given-names></name><name name-style="western"><surname>Rubagotti</surname><given-names>M</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>P</given-names></name><name name-style="western"><surname>Bertazzi</surname><given-names>PA</given-names></name></person-group><article-title>Cancer incidence in the population exposed to dioxin after the &#8220;Seveso accident&#8221;: twenty years of follow-up</article-title><source>Environ Health</source><year>2009</year><volume>8</volume><fpage>39</fpage><pub-id pub-id-type="pmid">19754930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1476-069X-8-39</pub-id><pub-id pub-id-type="pmcid">PMC2754980</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierre</surname><given-names>S</given-names></name><name name-style="western"><surname>Chevallier</surname><given-names>A</given-names></name><name name-style="western"><surname>Teixeira-Clerc</surname><given-names>F</given-names></name><etal/></person-group><article-title>Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin</article-title><source>Toxicological sciences: an official journal of the Society of Toxicology</source><year>2014</year><volume>137</volume><issue>1</issue><fpage>114</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">24154488</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kft236</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models</article-title><source>Pharmacol Rev</source><year>1994</year><volume>46</volume><issue>4</issue><fpage>483</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">7899475</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Kulju</surname><given-names>T</given-names></name><name name-style="western"><surname>Morselt</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain</article-title><source>Fundam Appl Toxicol</source><year>1989</year><volume>12</volume><issue>4</issue><fpage>698</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">2744273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0272-0590(89)90002-x</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Sankari</surname><given-names>S</given-names></name><name name-style="western"><surname>Kulju</surname><given-names>T</given-names></name><name name-style="western"><surname>Naukkarinen</surname><given-names>A</given-names></name><name name-style="western"><surname>Ylinen</surname><given-names>M</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Studies on the role of lipid peroxidation in the acute toxicity of TCDD in rats</article-title><source>Pharmacol Toxicol</source><year>1990</year><volume>66</volume><issue>5</issue><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">2371248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1990.tb00769.x</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Wong</surname><given-names>JM</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Harper</surname><given-names>PA</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name></person-group><article-title>Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain</article-title><source>Mol Pharmacol</source><year>1998</year><volume>54</volume><issue>1</issue><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9658193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/mol.54.1.86</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains</article-title><source>Toxicol Appl Pharmacol</source><year>1999</year><volume>155</volume><issue>1</issue><fpage>82</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">10036221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1998.8565</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pritchard</surname><given-names>C</given-names></name><name name-style="western"><surname>Coil</surname><given-names>D</given-names></name><name name-style="western"><surname>Hawley</surname><given-names>S</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>L</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>PS</given-names></name></person-group><article-title>The contributions of normal variation and genetic background to mammalian gene expression</article-title><source>Genome Biol</source><year>2006</year><volume>7</volume><issue>3</issue><fpage>R26</fpage><pub-id pub-id-type="pmid">16584536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2006-7-3-r26</pub-id><pub-id pub-id-type="pmcid">PMC1557746</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puga</surname><given-names>A</given-names></name><name name-style="western"><surname>Sartor</surname><given-names>MA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Gene expression profiles of mouse aorta and cultured vascular smooth muscle cells differ widely, yet show common responses to dioxin exposure</article-title><source>Cardiovasc Toxicol</source><year>2004</year><volume>4</volume><issue>4</issue><fpage>385</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">15531781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1385/ct:4:4:385</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quelard</surname><given-names>D</given-names></name><name name-style="western"><surname>Lavergne</surname><given-names>E</given-names></name><name name-style="western"><surname>Hendaoui</surname><given-names>I</given-names></name><etal/></person-group><article-title>A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><issue>4</issue><fpage>e1878</fpage><pub-id pub-id-type="pmid">18382662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0001878</pub-id><pub-id pub-id-type="pmcid">PMC2270346</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritz</surname><given-names>C</given-names></name><name name-style="western"><surname>Streibig</surname><given-names>JC</given-names></name></person-group><article-title>Bioassay analysis using R</article-title><source>J Statist Software</source><year>2005</year><volume>12</volume><issue>5</issue><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>S</given-names></name><name name-style="western"><surname>Shirakawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Tomita</surname><given-names>S</given-names></name><etal/></person-group><article-title>Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver</article-title><source>Toxicol Appl Pharmacol</source><year>2008</year><volume>229</volume><issue>1</issue><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">18295293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2007.12.029</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savino</surname><given-names>W</given-names></name><name name-style="western"><surname>Postel-Vinay</surname><given-names>MC</given-names></name><name name-style="western"><surname>Smaniotto</surname><given-names>S</given-names></name><name name-style="western"><surname>Dardenne</surname><given-names>M</given-names></name></person-group><article-title>The thymus gland: a target organ for growth hormone</article-title><source>Scand J Immunol</source><year>2002</year><volume>55</volume><issue>5</issue><fpage>442</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">11975755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-3083.2002.01077.x</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seppinen</surname><given-names>L</given-names></name><name name-style="western"><surname>Pihlajaniemi</surname><given-names>T</given-names></name></person-group><article-title>The multiple functions of collagen XVIII in development and disease</article-title><source>Matrix Biol</source><year>2011</year><volume>30</volume><issue>2</issue><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">21163348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.matbio.2010.11.001</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simanainen</surname><given-names>U</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name></person-group><article-title>Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains</article-title><source>Toxicol Appl Pharmacol</source><year>2002</year><volume>181</volume><issue>1</issue><fpage>38</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">12030841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.2002.9386</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simanainen</surname><given-names>U</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name></person-group><article-title>Dose-response analysis of short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in three differentially susceptible rat lines</article-title><source>Toxicol Appl Pharmacol</source><year>2003</year><volume>187</volume><issue>2</issue><fpage>128</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">12649045</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0041-008x(02)00068-6</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinkkonen</surname><given-names>S</given-names></name><name name-style="western"><surname>Paasivirta</surname><given-names>J</given-names></name></person-group><article-title>Degradation half-life times of PCDDs, PCDFs and PCBs for environmental fate modeling</article-title><source>Chemosphere</source><year>2000</year><volume>40</volume><issue>9&#8211;11</issue><fpage>943</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">10739030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0045-6535(99)00337-9</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorg</surname><given-names>O</given-names></name><name name-style="western"><surname>Zennegg</surname><given-names>M</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>P</given-names></name><etal/></person-group><article-title>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites</article-title><source>Lancet</source><year>2009</year><volume>374</volume><issue>9696</issue><fpage>1179</fpage><lpage>1185</lpage><pub-id pub-id-type="pmid">19660807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(09)60912-0</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staton</surname><given-names>AA</given-names></name><name name-style="western"><surname>Knaut</surname><given-names>H</given-names></name><name name-style="western"><surname>Giraldez</surname><given-names>AJ</given-names></name></person-group><article-title>miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><issue>3</issue><fpage>204</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">21258340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.758</pub-id><pub-id pub-id-type="pmcid">PMC3071589</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Storey</surname><given-names>JD</given-names></name><name name-style="western"><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><article-title>Statistical significance for genomewide studies</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><issue>16</issue><fpage>9440</fpage><lpage>9445</lpage><pub-id pub-id-type="pmid">12883005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1530509100</pub-id><pub-id pub-id-type="pmcid">PMC170937</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strobl</surname><given-names>JS</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>MJ</given-names></name></person-group><article-title>Human growth hormone</article-title><source>Pharmacol Rev</source><year>1994</year><volume>46</volume><issue>1</issue><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">8190748</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>G</given-names></name><name name-style="western"><surname>Hao</surname><given-names>M</given-names></name><etal/></person-group><article-title>CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression</article-title><source>Cancer Metastasis Rev</source><year>2010</year><volume>29</volume><issue>4</issue><fpage>709</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">20839032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10555-010-9256-x</pub-id><pub-id pub-id-type="pmcid">PMC3175097</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sweeney</surname><given-names>MH</given-names></name><name name-style="western"><surname>Mocarelli</surname><given-names>P</given-names></name></person-group><article-title>Human health effects after exposure to 2,3,7,8-TCDD</article-title><source>Food Addit Contam</source><year>2000</year><volume>17</volume><issue>4</issue><fpage>303</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">10912244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/026520300283379</pub-id></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarnowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name><name name-style="western"><surname>Wysoczynski</surname><given-names>M</given-names></name><name name-style="western"><surname>Ratajczak</surname><given-names>J</given-names></name><name name-style="western"><surname>Kucia</surname><given-names>M</given-names></name><name name-style="western"><surname>Ratajczak</surname><given-names>MZ</given-names></name></person-group><article-title>CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells</article-title><source>Eur J Haematol</source><year>2010</year><volume>85</volume><issue>6</issue><fpage>472</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">20887389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0609.2010.01531.x</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tijet</surname><given-names>N</given-names></name><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name><name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name></person-group><article-title>Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries</article-title><source>Mol Pharmacol</source><year>2006</year><volume>69</volume><issue>1</issue><fpage>140</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">16214954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/mol.105.018705</pub-id></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tryon</surname><given-names>WW</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>C</given-names></name></person-group><article-title>An inferential confidence interval method of establishing statistical equivalence that corrects Tryon&#8217;s (2001) reduction factor</article-title><source>Psychol Methods</source><year>2008</year><volume>13</volume><issue>3</issue><fpage>272</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">18778155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/a0013158</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name></person-group><article-title>Is the fear of dioxin cancer more harmful than dioxin?</article-title><source>Toxicol Lett</source><year>2012</year><volume>210</volume><issue>3</issue><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">22387160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2012.02.007</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced anorexia and wasting syndrome in rats: aggravation after ventromedial hypothalamic lesion</article-title><source>Eur J Pharmacol</source><year>1995</year><volume>293</volume><issue>4</issue><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">8748683</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0926-6917(95)90050-0</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines</article-title><source>Toxicol Appl Pharmacol</source><year>1999</year><volume>155</volume><issue>1</issue><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10036220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1998.8564</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>E</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: relationship with TCDD lethality</article-title><source>Toxicol Appl Pharmacol</source><year>1994</year><volume>128</volume><issue>2</issue><fpage>280</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">7940543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1994.1208</pub-id></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds on the central nervous system</article-title><source>Int J Biochem Cell Biol</source><year>1995</year><volume>27</volume><issue>5</issue><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">7641074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/1357-2725(95)00023-i</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Body weight loss and changes in tryptophan homeostasis by chlorinated dibenzo-p-dioxin congeners in the most TCDD-susceptible and the most TCDD-resistant rat strain</article-title><source>Arch Toxicol</source><year>1998</year><volume>72</volume><issue>12</issue><fpage>769</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">9950073</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002040050572</pub-id></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>J</given-names></name></person-group><article-title>Dioxin-induced perturbations in tryptophan homeostasis in laboratory animals</article-title><source>Adv Exp Med Biol</source><year>1999</year><volume>467</volume><fpage>433</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">10721086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4615-4709-9_55</pub-id></element-citation></ref><ref id="CR88"><mixed-citation publication-type="other">US-EPA (2003) Dioxin reassessment: draft exposure and human health reassessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds national academy sciences (NAS) review draft part II: health assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cfpub.epa.gov/ncea/iris_drafts/dioxin/nas-review/index.cfm">https://cfpub.epa.gov/ncea/iris_drafts/dioxin/nas-review/index.cfm</ext-link></mixed-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Birgelen</surname><given-names>AP</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>M</given-names></name></person-group><article-title>Toxicokinetics</article-title><source>Food Addit Contam</source><year>2000</year><volume>17</volume><issue>4</issue><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">10912241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/026520300283342</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vezina</surname><given-names>CM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Olson</surname><given-names>JR</given-names></name></person-group><article-title>Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression</article-title><source>Environ Health Perspect</source><year>2004</year><volume>112</volume><issue>16</issue><fpage>1636</fpage><lpage>1644</lpage><pub-id pub-id-type="pmid">15598615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/txg.7253</pub-id><pub-id pub-id-type="pmcid">PMC1247661</pub-id></element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name><name name-style="western"><surname>Unkila</surname><given-names>M</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains</article-title><source>Arch Toxicol</source><year>1999</year><volume>73</volume><issue>6</issue><fpage>323</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">10447560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002040050626</pub-id></element-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viluksela</surname><given-names>M</given-names></name><name name-style="western"><surname>Bager</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains</article-title><source>Cancer Res</source><year>2000</year><volume>60</volume><issue>24</issue><fpage>6911</fpage><lpage>6920</lpage><pub-id pub-id-type="pmid">11156390</pub-id></element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vorderstrasse</surname><given-names>BA</given-names></name><name name-style="western"><surname>Steppan</surname><given-names>LB</given-names></name><name name-style="western"><surname>Silverstone</surname><given-names>AE</given-names></name><name name-style="western"><surname>Kerkvliet</surname><given-names>NI</given-names></name></person-group><article-title>Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression</article-title><source>Toxicol Appl Pharmacol</source><year>2001</year><volume>171</volume><issue>3</issue><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">11243915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.2000.9122</pub-id></element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waggott</surname><given-names>D</given-names></name><name name-style="western"><surname>Chu</surname><given-names>K</given-names></name><name name-style="western"><surname>Yin</surname><given-names>SW</given-names></name><name name-style="western"><surname>Bradly</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F-F</given-names></name><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name></person-group><article-title>An extensible R package for the pre-processing of nanostring mRNA and miRNA data</article-title><source>Bioinformatics</source><year>2011</year><volume>28</volume><issue>11</issue><fpage>1546</fpage><lpage>1548</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/bts188</pub-id><pub-id pub-id-type="pmcid">PMC3356845</pub-id><pub-id pub-id-type="pmid">22513995</pub-id></element-citation></ref><ref id="CR95"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walisser</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bunger</surname><given-names>MK</given-names></name><name name-style="western"><surname>Glover</surname><given-names>E</given-names></name><name name-style="western"><surname>Bradfield</surname><given-names>CA</given-names></name></person-group><article-title>Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><issue>47</issue><fpage>16677</fpage><lpage>16682</lpage><pub-id pub-id-type="pmid">15545609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0404379101</pub-id><pub-id pub-id-type="pmcid">PMC534507</pub-id></element-citation></ref><ref id="CR96"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walisser</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bunger</surname><given-names>MK</given-names></name><name name-style="western"><surname>Glover</surname><given-names>E</given-names></name><name name-style="western"><surname>Harstad</surname><given-names>EB</given-names></name><name name-style="western"><surname>Bradfield</surname><given-names>CA</given-names></name></person-group><article-title>Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>16</issue><fpage>16326</fpage><lpage>16331</lpage><pub-id pub-id-type="pmid">14764592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M400784200</pub-id></element-citation></ref><ref id="CR97"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walters</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ebsworth</surname><given-names>K</given-names></name><name name-style="western"><surname>Berahovich</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats</article-title><source>Br J Cancer</source><year>2014</year><volume>110</volume><issue>5</issue><fpage>1179</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">24423923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/bjc.2013.830</pub-id><pub-id pub-id-type="pmcid">PMC3950859</pub-id></element-citation></ref><ref id="CR98"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>JD</given-names></name><name name-style="western"><surname>Prokopec</surname><given-names>SD</given-names></name><name name-style="western"><surname>Smith</surname><given-names>AB</given-names></name><name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Pohjanvirta</surname><given-names>R</given-names></name><name name-style="western"><surname>Boutros</surname><given-names>PC</given-names></name></person-group><article-title>TCDD dysregulation of 13 AHR-target genes in rat liver</article-title><source>Toxicol Appl Pharmacol</source><year>2013</year><pub-id pub-id-type="pmid">24355419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2013.12.004</pub-id></element-citation></ref><ref id="CR99"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>LW</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>CD</given-names></name><name name-style="western"><surname>Rozman</surname><given-names>K</given-names></name></person-group><article-title>Reduced activity of tryptophan 2,3-dioxygenase in the liver of rats treated with chlorinated dibenzo-p-dioxins (CDDs): dose-responses and structure-activity relationship</article-title><source>Toxicology</source><year>1994</year><volume>86</volume><issue>1&#8211;2</issue><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">7907825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(94)90053-1</pub-id></element-citation></ref><ref id="CR100"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>SS</given-names></name><name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name></person-group><article-title>An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology</article-title><source>J Environ Sci Health C Environ Carcinog Ecotoxicol Rev</source><year>2009</year><volume>27</volume><issue>4</issue><fpage>197</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">19953395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10590500903310047</pub-id><pub-id pub-id-type="pmcid">PMC2788749</pub-id></element-citation></ref><ref id="CR101"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>CQ</given-names></name><name name-style="western"><surname>Prokopec</surname><given-names>SD</given-names></name><name name-style="western"><surname>Watson</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title><source>Toxicol Appl Pharmacol</source><year>2012</year><volume>260</volume><issue>2</issue><fpage>135</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">22342509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2012.02.001</pub-id></element-citation></ref><ref id="CR102"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Inhibition of T-type Ca(2&#160;+) channels by endostatin attenuates human glioblastoma cell proliferation and migration</article-title><source>Br J Pharmacol</source><year>2012</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1476-5381.2012.01852.x</pub-id><pub-id pub-id-type="pmcid">PMC3417444</pub-id><pub-id pub-id-type="pmid">22233416</pub-id></element-citation></ref><ref id="CR103"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>C</given-names></name><name name-style="western"><surname>Pu</surname><given-names>LY</given-names></name><name name-style="western"><surname>Fang</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rao</surname><given-names>JH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XH</given-names></name></person-group><article-title>Retinoic acid receptor alpha promotes autophagy to alleviate liver ischemia and reperfusion injury</article-title><source>World J Gastroenterol</source><year>2015</year><volume>21</volume><issue>43</issue><fpage>12381</fpage><lpage>12391</lpage><pub-id pub-id-type="pmid">26604645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v21.i43.12381</pub-id><pub-id pub-id-type="pmcid">PMC4649121</pub-id></element-citation></ref><ref id="CR104"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuo</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Endostatin specifically targets both tumor blood vessels and lymphatic vessels</article-title><source>Front Med</source><year>2011</year><volume>5</volume><issue>4</issue><fpage>336</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">22198745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11684-011-0163-5</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>